<DOC>
	<DOC>NCT02206841</DOC>
	<brief_summary>This study is designed for establishment of non-alcoholic fatty liver disease patients cohort to development of markers to predict histologic progression of liver fibrosis.</brief_summary>
	<brief_title>Establishment of NAFLD Cohort and Development of Fibrosis Markers</brief_title>
	<detailed_description>- Acoustic radiation force impulse elastography - Liver tissue (frozen tissue, paraffin block) - Whole blood, Serum - Fat amount ratio CT (Visceral adipose tissue, Subcutaneous adipose tissue amount) - Body composition analyzer (InBody scale):Total fat/muscle mass and appendicular skeletal muscle mass</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>Patients with histologically confirmed fatty liver disease Patients with radiologically confirmed fatty liver disease History of significant alcohol consumption Viral hepatitis Autoimmune hepatitis Metabolic diseases (e.g. hemochromatosis, M. Wilson, alpha 1antitrypsin deficiency) Hepatotoxic medication (e.g. amiodarone)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>fibrosis</keyword>
	<keyword>markers</keyword>
</DOC>